9-methyl-beta-carboline has been researched along with Idiopathic Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gille, G; Polanski, W; Reichmann, H | 1 |
1 review(s) available for 9-methyl-beta-carboline and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Stimulation, protection and regeneration of dopaminergic neurons by 9-methyl-β-carboline: a new anti-Parkinson drug?
Topics: Animals; Antiparkinson Agents; Brain; Carbolines; Dopamine; Humans; Nerve Regeneration; Neurons; Neuroprotective Agents; Parkinson Disease | 2011 |